Health

U.S. FDA Granted Priority Review to Dizal's Sunvozertinib New Drug Application

* If approved, Sunvozertinib as a single oral drug would offer a convenient and safe treatment option with superior efficacy for NSCLC patients with EGFR exon20ins * Sunvozertinib's NDA was submitted based on the multinational pivotal WU-KONG1 Part B study, the results of which were presented...

2025-01-07 18:00 1136

Weimai bags RMB200m in Series D funding to enhance tech-enabled, continuous healthcare services

The latest funding round will fuel Weimai's efforts to expand its full-cycle healthcare solutions, leveraging AI and digital tools to provide comprehensive care acrossChina HANGZHOU, China, Jan. 7, 2025 /PRNewswire/ -- Weimai, a leading provider of one-stop digital healthcare solutions inChina, ...

2025-01-07 16:19 1516

UnionPay International Partners with P.MED and StudyPENANG to Enhance Penang's Healthcare and Education Sectors, Strengthening its Position as the Preferred Payment Solution for International Tourists and Students

GEORGE TOWN, Malaysia, Jan. 7, 2025 /PRNewswire/ -- UnionPay International, a global leader in payment solutions, is proud to announce a landmark partnership with the Penang Centre for Medical Tourism (P.MED) and StudyPENANG. This strategic collaboration reinforces UnionPay International's commit...

2025-01-07 15:43 3334

Akeso to Share Global Strategy for New Drug Development at the 43rd J.P. Morgan Healthcare Conference

HONG KONG and SAN FRANCISCO, Jan. 6, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce its participation in the upcoming 43rd Annual J.P. Morgan Healthcare Conference, taking place onJanuary 13, 2025, in San Francisco, California. The company's founder, ...

2025-01-07 11:18 1184

NUS researchers boost chemotherapy uptake in breast cancer treatment with localised magnetic fields

A recent study explained the mechanisms by which pulsed electromagnetic field therapy enhances doxorubicin uptake, paving the way for precision-driven cancer therapies with fewer side effects SINGAPORE, Jan. 6, 2025 /PRNewswire/ -- Researchers at the National University of Singapore (NUS) have d...

2025-01-07 09:33 1019

The Registrational Clinical Data of Glecirasib was Published in Nature Medicine

BEIJING, SHANGHAI and BOSTON, Jan. 6, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets announced today that the data from a registrational clinical trial of its independently developed KRAS G12C inhibitor glecirasib has been publishe...

2025-01-07 08:30 1016

WuXi Biologics Announces Agreement with Candid Therapeutics on Trispecific T-cell Engager

SHANGHAI and SAN DIEGO, Jan. 6, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO),today announced an agreement with Candid Therapeutics, Inc. ("Candid"), a clinical-stage biotechnology company focus...

2025-01-07 08:00 1006

Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma

Back to media releases Next media release LONDON, Jan. 7, 2025 /PRNewswire/ -- Nor...

2025-01-07 08:00 1175

DXC Technology's AI Impact Helps Customers Across Industries Innovate with AI

AI Impact leverages DXC's combined consulting, engineering, and secure enterprise services ASHBURN, Va., Jan. 6, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, today announced AI Impact, an approach designed to help solve customers' mo...

2025-01-06 23:36 2505

VIV™ Ring: The World's 1st Smart Ring with Generative Sleep Aid Sound at CES 2025

* The Intuitive Smart Ring Challenging Oura and Galaxy Ring * Generative Sleep Aid Sound Enhancing Beyond Biometrics Measurement LAS VEGAS ,Jan. 6, 2025 /PRNewswire/ -- VIV Health is thrilled to announce the upcoming launch of the VIV™ Ring, the world's first smart ring equipped with Generative...

2025-01-06 23:30 1160

Momcozy 2024 Year in Review: Capturing the Power of Comfort and Growth

NEW YORK, Jan. 6, 2025 /PRNewswire/ -- The global one-stop mother and baby brand Momcozy has unveiled its annual review video alongside a user testimonial video. In its annual review, Momcozy highlighted key achievements of 2024, showcasing its commitment to empowering mothe...

2025-01-06 23:00 822

Datasea Announces Entry into Agreements that Will Place its Acoustic High-Tech Products in a Total of 263 Beauty Stores in Northern China

The New Agreements Projected to Generate Sales of up to 140,000 Units and $11 Million in Revenue by Year End 2025 BEIJING, Jan. 6, 2025 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS, "Datasea" or "the Company"), aNevada-based digital technology company specializing in acoustic high-tech and 5G AI m...

2025-01-06 22:45 2798

EMSRUN Medical Celebrates 15 Years of Excellence in Life-Saving Solutions

WUXI, China, Jan. 6, 2025 /PRNewswire/ -- EMSRUN Medical, a leader in tactical, pre-hospital, and civilian emergency medical solutions, marks its 15th anniversary this year. Since its establishment in 2010, the company has built an outstanding reputation for delivering critical solutions to comba...

2025-01-06 22:10 1225

Hanyang University, Korea's Pioneer in Industry-Academia Collaboration, Debuts First Independent Pavilion at CES 2025

Featuring 13 groundbreaking innovations, including this year's Best of Innovation Award in Digital Health, to drive transformative solutions for societal change SEOUL, South Korea, Jan. 6, 2025 /PRNewswire/ -- Hanyang University, a global leader in industry-academia collaboration, is proud to an...

2025-01-06 22:00 1299

Technoderma Medicines Completes Positive Ph2a Proof- of Concept Trial with Topical TDM-180935 Ointment for Atopic Dermatitis

CHENGDU, China, Jan. 6, 2025 /PRNewswire/ -- Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased to report the Company has completed its Phase 2a clinical trial (NCT06363461) of topical TDM-180935 ointment in patients with Atopic Dermatitis (AD). Th...

2025-01-06 21:00 1283

Concord Medical Announces Result of 2024 Annual General Meeting

BEIJING, Jan. 6, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced that it held its 2024 annual general meeting of shar...

2025-01-06 20:30 2380

I-Mab Announces Portfolio Prioritization of Givastomig (CLDN18.2 x 4-1BB Bispecific Antibody) as Lead Clinical Program

* Givastomig: a Claudin 18.2 ("CLDN18.2") x 4-1BB bispecific antibody, will be the lead clinical program following the Company's portfolio prioritization * The Company has completed enrollment of a dose escalation study of givastomig in combination with nivolumab plus chemotherapy, anddata is ...

2025-01-06 20:00 904

Asieris and CDC Sign Investigational Product Supply Agreement for APL-1202 in Free-Living Amoeba Infections Treatment under Expanded Access Investigational New Drug Program

SHANGHAI, Jan. 6, 2025 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a leading global biopharmaceutical company dedicated to advancing innovative therapies for genitourinary tumors and women's health with significant unmet medical needs, announced the signing of an investigatio...

2025-01-06 18:05 1172

Spectricity Unveils S1-A Accessory Device for Plug-n-Play Spectral Imaging on Mobile Platforms

The S1-A Accessory Device will be revealed together with Spectricity's latest Skin Analysis demonstration at CES 2025, Westgate Hotel, Suite #12-121. MECHELEN, Belgium, Jan. 6, 2025 /PRNewswire/ -- Spectricity, a leading provider of multispectral imaging solutions for mobile devices, today announ...

2025-01-06 12:16 1985

Docquity and HCDC Partner to Strengthen Preventive Medicine Education for Thousands of HCPs in Vietnam

Through this multi-year initiative, HCDC will tap on Docquity's digital capabilities and reach to arm over 3,000 HCPs across diverse fields with breakthroughs in preventive medicine HO CHI MINH, Vietnam, Jan. 6, 2025 /PRNewswire/ -- Docquity, Southeast Asia's largest community of healthcare prof...

2025-01-06 11:00 1440
12345678 ... 871